Article Summary
张雨点,谢锦艳,李小川,张志杰,李 珍.木犀草素是具有PPARγ激动剂活性的新型AMPK激活剂[J].现代生物医学进展英文版,2019,19(9):1601-1607.
木犀草素是具有PPARγ激动剂活性的新型AMPK激活剂
Luteolin is a Novel AMPK Activator with Partial PPARγ Agonist Activity
Received:July 28, 2018  Revised:August 23, 2018
DOI:10.13241/j.cnki.pmb.2019.09.001
中文关键词: 木犀草素  PPARγ  AMPK  脂联素  胰岛素敏感性
英文关键词: Luteolin  PPARγ  AMPK  Adiponectin  Insulin Sensitivity
基金项目:国家自然科学基金项目(31570760)
Author NameAffiliationE-mail
ZHANG Yu-dian MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing, 100084, China yudian_zhang@163.com 
XIE Jin-yan Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China  
LI Xiao-chuan MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing, 100084, China  
ZHANG Zhi-jie Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China  
LI Zhen MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing, 100084, China  
Hits: 984
Download times: 602
中文摘要:
      摘要 目的:木犀草素是一种天然黄酮类化合物,早期报导其能激活PPARγ,本实验室发现其也能激活AMPK。因此本研究验证木犀草素在脂肪细胞中能否激活PPARγ和AMPK,并探究这两种活性对脂肪前体细胞分化及脂联素高聚化的影响。方法:使用LanthaScreen TR-FRET PPARγ竞争性结合检测试剂盒检测木犀草素与PPARγ的结合能力,并用PPRE转录激活报告基因体系验证木犀草素是否激活PPARγ转录活性,利用油红O染色法检测木犀草素对3T3-L1脂肪前体细胞分化的影响,采用RNA干扰沉默成熟脂肪细胞中AMPKα1,用Western Blot检测相关蛋白水平。结果:木犀草素能直接结合PPARγ,其IC50为1880 nmoL?L-1,并显示剂量依赖的PPARγ转录激活活性,抑制PPARγ Ser-273位点磷酸化。木犀草素能升高pAMPK(Thr-172)水平,抑制脂肪前体细胞分化,升高脂联素高聚化水平。结论:木犀草素通过激活AMPK和PPARγ调控脂肪前体细胞分化和脂联素高聚化,是一种具有PPARγ激动剂活性的新AMPK激活剂,有望成为治疗Ⅱ型糖尿病和肥胖等代谢紊乱疾病的潜在药物。
英文摘要:
      ABSTRACT Objective: In this study, we reported that luteolin, a natural flavonoid with partial PPARγ-agonist activity, also acti- vates AMPK, and investigated the effects of luteolin on preadipocytes differentiation and adiponectin multimerization in adipocytes. Methods: In vitro binding of luteolin to PPARγ was analyzed by a LanthaScreen time-resolved fluorescent energy transfer (TR-FRET) PPARγ competitive binding assay; the effect of luteolin on the transcriptional activity of PPARγ was examined by luciferase reporter assays; the effect of luteolin on preadipocytes differentiation was examined by Oil Red O staining; mature 3T3-L1 adipocytes transfected with mouse AMPKα1 siRNA were treated with luteolin to detect the levels of total adiponectin and adiponectin oligomers. Results: The competitive binding assay confirmed direct binding of luteolin to the LBD of PPARγ with IC50 being 1880 nmoL?L-1. Luteolin dose-de- pendently increased the transcriptional activity of PPARγ and inhibited the phosphorylation of PPARγ at Ser-273. Luteolin increased the level of pAMPK(Thr-172), inhibited preadipocytes differentiation, and increased the level of high molecular weight adiponectin (HMW). Conclusion: Luteolin is a novel AMPK activator with partial PPARγ agonist activity. Luteolin inhibits preadipocytes differen- tiation and promotes multimerization of adiponectin by activating both AMPK and PPARγ. The dual-activity makes luteolin a potential insulin sensitizer for the treatment of type II diabetes.
View Full Text   View/Add Comment  Download reader
Close